NUVB FY 2024 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M

Gross Profit

$795,00010.1% margin

Operating Income

-$593M-7527.3% margin

Net Income

-$568M-7213.8% margin

EPS (Diluted)

$-2.11

Cash Flow

Operating Cash Flow

-$130M

Free Cash Flow

-$131M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$541M

Total Liabilities

$77M

Stockholders' Equity

$464M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$0	—
Gross Profit	$795,000	$0	—
Operating Income	-$593M	-$100M	-493.7%
Net Income	-$568M	-$76M	-649.2%